Compounds > cyproterone acetate, ethinyl estradiol drug combination
Page last updated: 2024-08-26

cyproterone acetate, ethinyl estradiol drug combination and Adverse Drug Event

cyproterone acetate, ethinyl estradiol drug combination has been researched along with Adverse Drug Event in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Collier, R1
Kant, AC; van Hunsel, FP; van Puijenbroek, EP1

Other Studies

2 other study(ies) available for cyproterone acetate, ethinyl estradiol drug combination and Adverse Drug Event

ArticleYear
Scrutiny of Diane-35 due to potential dangers of off-label prescribing.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2013, Mar-19, Volume: 185, Issue:5

    Topics: Canada; Cyproterone Acetate; Drug Combinations; Drug Labeling; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Ethinyl Estradiol; Female; Humans; Off-Label Use; Safety-Based Drug Withdrawals

2013
[Thrombosis and embolism during Diane-35 use: analysis of reports made to the Netherlands Pharmacovigilance Centre Lareb].
    Nederlands tijdschrift voor geneeskunde, 2014, Volume: 158

    Topics: Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Embolism; Ethinyl Estradiol; Female; Humans; Male; Netherlands; Pharmacovigilance; Risk Factors; Thrombosis

2014